finalised Category XII of the US Munitions List and Category VI of the Commerce Control List. Te comment period for these

NOIs closed on 14 March. From reviewing the public responses, it appears companies generally would like to see the regulations, which went into effect on 30 December 2016, remain as written. Te State Department’s NOI

contained proposed parameters to replace usage of ‘specially designed’ in Category XII. Many of those who commented found the proposed control structure listed in the notice confusing and one that would limit future growth in the technologies listed. Te Commerce Department’s NOI proposed additional controls for dual-use infrared detection items. Te vast majority of the comments stated that additional controls were not warranted based on the international availability of the items listed in this NOI. It is unclear at this time if any further

action will be taken regarding the proposed language in the NOIs.

Infrared technology advances Advances in infrared covered by these NOIs are broadly shared throughout the community worldwide. Tough the US is a part of the elite community of government and private-sector researchers who are continuing to further this technology, they are by far not alone. While the current market shares

of Europe and the Asia-Pacific regions are smaller than the United States, Asia-Pacific in particular offers greater potential future growth opportunities because the ongoing ‘commoditisation’ of the underlying IR technologies. Technology commoditisation will continue to be a major market trend as IR sensing capabilities are combined with smartphone cameras and become as ubiquitous as visible wavelength cameras.

Companies are finding it more difficult to maintain US-based manufacturing capabilities for critical technologies

Teir development will continue to erode the cost of access to IR imaging at all levels, making this technology more widely accessible than ever before. Te overall global market for IR imaging was $6.43 billion in 2015, according to a July 2016 report from Marketsandmarkets, which also projects the market will grow at a CAGR of 8.32 per cent between 2016 and 2022 In addition, manufacture and

assembly of these components and systems is becoming increasingly

globalised as optics and photonics manufacturing capabilities continue to migrate out of the United States. As a result, companies are finding it ever more difficult to maintain US- based manufacturing capabilities for critical technologies when the larger commercial markets are restricted due to ITAR controls.

Get involved It is important that companies and universities keep the US government informed about the constant evolution and growth of the technology governed by export controls in order to assist regulators seeking to institute well-written and precise regulations that balance the realities of commercial availability and competition with national security needs. Members of the public with US-based companies or universities are welcome to join SPIE’s export control working groups. More information can be found at O

Your choices . Our expertise.

Active Silicon designs and manufactures embedded systems customized for specific OEM applications, such as medical devices, industrial automation or security, and often integrates our leading-edge image acquisition technology.

Europe & Asia: Tel: +44 (0) 1753 650600 Fax: +44 (0) 1753 651661

North America: Tel: +1 410 696 7672 Fax: +1 410 696 7643

Meeting various safety, quality and medical standards as appropriate, our systems provide for a long product life - retaining the same form, fit and function for many years.

Tell us what you need and benefit from our expertise.

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56